OMER

Maxim Group analyst Jason McCarthy maintained a Hold rating on Omeros (OMER - Research Report) yesterday. The company's shares opened today at $2.65.According to TipRanks, McCarthy is an analyst with an average return of -38.2% and a 16.67% success rate. McCarthy covers the Healthcare sector, focusing on stocks such as Immutep, Daré Bioscience, and Adial Pharmaceuticals.In addition to Maxim Group, Omeros also received a Hold from Needham's Serge Belanger in a report issued on November 10. However, on the same day, Cantor Fitzgerald maintained a Buy rating on Omeros (NASDAQ: OMER).See today’s best-performing stocks on TipRanks >>The company has a one-year high of $8.45 and a one-year low of $1.86.
https://www.tipranks.com/news/blurbs/maxim-group-keeps-their-hold-rating-on-omeros-omer-2?utm_source=advfn.com&utm_medium=referral